Heteroaromatic NMDA receptor modulators and uses thereof
US10626122B2 · kind B2 · utility
7Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2016 |
| Grant date | Apr 21, 2020 |
| Priority date | — |
| Expiry date | Dec 9, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/519
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated modulate the NMDA receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.